Metabolomic Technologies Company
Metabolomic Technologies develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
Founded Date:
2010-01-01
Last Funding Type:
Series A
Headquarters:
Edmonton, Alberta, Canada
Investors Number:
4
Employee Number:
11-50
Industry:
Anti-aging Therapies
Estimated Revenue:
Less than $1M
Last Funding Date:
2019-10-22
Funding Status:
Early Stage Venture
Total Funding:
4575000